TAFRO syndrome: a case report
- Shan Meng
, - Hailing Liu,
- Wang-Gang Zhang,
- Aili He,
- Honghong Sun,
- Ru Zhang,
- Xiaoli Chen,
- Yinxia Chen
Abstract
A man diagnosed as TAFRO syndrome was successfully responded to a novel
immunosuppressive regimen containing methylprednisolone and
mycophenolate mofetil. Blood cells firstly recovered, followed by the
general situation and complete recover 1 month later, highlighting the
danger of TAFRO syndrome and the importance of immunosuppressive agents
in reversing pathological course07 Nov 2021Submitted to Clinical Case Reports 08 Nov 2021Submission Checks Completed
08 Nov 2021Assigned to Editor
10 Nov 2021Reviewer(s) Assigned
11 Jan 2022Review(s) Completed, Editorial Evaluation Pending
30 Jan 2022Editorial Decision: Revise Minor
28 Mar 20221st Revision Received
29 Mar 2022Submission Checks Completed
29 Mar 2022Assigned to Editor
29 Mar 2022Review(s) Completed, Editorial Evaluation Pending
21 May 2022Editorial Decision: Accept
